Andy B Lassman

23PUBLICATIONS
149CO-AUTHORS
Biological adaptationMining, energy and natural resources lawMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Aug 08, 2025
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.

Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto

|Apr 29, 2025
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update.

Jaishri Blakeley, Nimish A Mohile, Hans Messersmith

|Sep 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.

Patrick Y Wen, Martin van den Bent, Gilbert Youssef

|Apr 16, 2023
A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.

Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn

Pageof 4

Frequent Collaborators

7 joint publications

Martin van den Bent

6 joint publications

David Schiff

4 joint publications

Jaishri Blakeley

4 joint publications

Mei-Yin C Polley